Riskpilot← Back to searchSign inGet full accessThy Lækagesporing ApS
APSActiveCVR 25148371Norsvej 2Technical testing and analysis · NACE 7120Est. 20005 employees
Revenue 2025
DKK 5,7M
+13% vs 2024
EBITDA margin
47.8%
+28% vs 2024
Equity ratio
64.4%
Financial strength
Net profit 2025
DKK 1,9M
+33% vs 2024
| Revenue | DKK 5,7M | +13% |
| EBITDA | DKK 2,7M | +28% |
| Net profit | DKK 1,9M | +33% |
| Total assets | DKK 3,8M | -9% |
| Equity | DKK 2,4M | -19% |
| Employees | 5 | — |
Legal name
Thy Lækagesporing ApS
CVR number
25148371
Legal form
Anpartsselskab
NACE code
7120 · Technical testing and analysis
Founded
17. januar 2000
Share capital
DKK 241.000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af et medlem af direktionen
Company purpose
Selskabets formål er at drive virksomhed med lækagesporing samt hermed beslægtet virksomhed.
Address
Norsvej 2
Phone
+4597982273
Email
mail@thy-laekage.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -2.961 | -3.164 | — | — | 3.282 | 3.262 | 4.137 | 3.771 | 3.731 | 4.602 | 4.629 | 5.220 | 5.004 | 5.666 |
| Staff expenses | -1.613 | -1.687 | -0 | -0 | -1.640 | -1.863 | -1.997 | -2.224 | -2.131 | -1.968 | -2.227 | -2.697 | -2.889 | -2.912 |
| EBITDA | -676 | -827 | 0 | 0 | 1.642 | 1.399 | 2.140 | 1.547 | 1.600 | 2.634 | 2.402 | 2.523 | 2.115 | 2.711 |
| Depreciation & amort. | -336 | -325 | -0 | -0 | -260 | -272 | -211 | -245 | -276 | -236 | -230 | -260 | -251 | -263 |
| EBIT | -1.012 | -1.152 | 0 | 0 | 1.382 | 1.127 | 1.930 | 1.302 | 1.324 | 2.397 | 2.172 | 2.263 | 1.864 | 2.448 |
| Net financials | -46 | -23 | 0 | 0 | 54 | 71 | -85 | -2 | -1 | -3 | -6 | -2 | 18 | 22 |
| Profit before tax | -980 | -1.175 | 0 | 0 | 1.436 | 1.199 | 1.844 | 1.300 | 1.323 | 2.394 | 2.166 | 2.261 | 1.883 | 2.470 |
| Tax | -246 | -294 | -0 | -0 | 317 | 264 | 417 | 287 | 293 | 527 | 479 | 496 | 432 | 542 |
| Net profit | -735 | -881 | 0 | 0 | 1.119 | 935 | 1.427 | 1.014 | 1.030 | 1.867 | 1.687 | 1.765 | 1.451 | 1.928 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2.839 | 2.614 | 0 | 0 | 0 | 3.065 | 3.840 | 3.764 | 4.345 | 4.944 | 3.899 | 4.243 | 4.127 | 3.767 |
| Equity | 1.792 | 1.673 | 0 | 0 | 0 | 1.909 | 2.436 | 2.200 | 2.730 | 3.096 | 2.784 | 3.049 | 3.000 | 2.427 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 197 | 165 | 0 | 0 | 0 | 0 |
| Short-term debt | -989 | -893 | 0 | 0 | 0 | 1.113 | 1.355 | 1.499 | 1.344 | 1.609 | 1.032 | 1.104 | 1.045 | 1.233 |
| Total debt | -989 | -893 | 0 | 0 | 0 | 1.113 | 1.355 | 1.499 | 1.541 | 1.774 | 1.032 | 1.104 | 1.045 | 1.233 |
EBITDA margin
47.8%
This company
15.8%
Market median
+203% vs market
20122025
Equity ratio
64.4%
This company
38.2%
Market median
+69% vs market
20122025
Return on equity
79.4%
This company
18.4%
Market median
+332% vs market
20122025
Net profit margin
34.0%
This company
8.1%
Market median
+320% vs market
20122025
Asset turnover
1.50×
This company
1.12×
Market median
+34% vs market
20122025
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via CVR / Virk · Period 2017-07-01 – 2018-06-30
- Annual report 2017Filed via CVR / Virk · Period 2016-07-01 – 2017-06-30
- Annual report 2016Filed via CVR / Virk · Period 2015-07-01 – 2016-06-30
- Annual report 2015Filed via CVR / Virk · Period 2014-07-01 – 2015-06-30
- Annual report 2014Filed via CVR / Virk · Period 2013-07-01 – 2014-06-30
- Annual report 2013Filed via CVR / Virk · Period 2012-07-01 – 2013-06-30
- Annual report 2012Filed via CVR / Virk · Period 2011-07-01 – 2012-06-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
AH Management | Management | 2002 | — | — |
JO Founder | Founder | 2000 | — | — |
PR Management | Management | 2002 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
SPORHUNDEN HOLDING ApS | Company | 50.0% | 50.0% | 2025 |
RC Holding Nors ApS | Company | 25.0% | 25.0% | 2024 |
Stine Riis Holding ApS | Company | 10.0% | 10.0% | 2025 |
Sara Riis Holding ApS | Company | 10.0% | 10.0% | 2022 |
J.O.J. HOLDING ApS | Company | 20.0% | 20.0% | 2016 |
SPORVOGNEN HOLDING ApS | Company | 33.3% | 33.3% | 2013 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SPORHUNDEN HOLDING ApS
Thy Lækagesporing ApS Board members of Thy Lækagesporing ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anders Henrik Jensen | Management | 0 companies |
| Jens Ole Jensen | Founder | 0 companies |
| Philip Riis Christensen | Management | 0 companies |